Lipustobart
Lipustobart is an IgG4-kappa, anti-PDCD1 (programmed cell death 1, PD1, PD-1, CD279) humanized monoclonal antibody. Lipustobart shows immunostimulant and antineoplastic activity[1].
Product Specifications
CAS Number
2639481-06-2
Product Name Alternative
LZM-009
UNSPSC
12352203
Hazard Statement
H302, H315, H319, H335
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lipustobart.html
Purity
99.9
Solubility
H2O
Smiles
[Lipustobart]
Molecular Weight
(146.101 kDa)
Precautions
H302, H315, H319, H335
References & Citations
[1]International Nonproprietary Names for Pharmaceutical Substances (INN) . WHO Drug Information, Vol. 36, No. 2, 2022.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6495034-01 0.1 mL
PGP9.5, CT (Ubiquitin Carboxyl-terminal Hydrolase Isozyme L1, UCH-L1, Ubiquitin Thiolesterase L1, Neuron Cytoplasmic Protein 9.5, UCHL1) (MaxLight 650)
Sign In for Pricing
View Details MBS6495034-02 5x 0.1 mL
PGP9.5, CT (Ubiquitin Carboxyl-terminal Hydrolase Isozyme L1, UCH-L1, Ubiquitin Thiolesterase L1, Neuron Cytoplasmic Protein 9.5, UCHL1) (MaxLight 650)
Sign In for Pricing
View Details 
MBS2122851-01 0.01 mg
Recombinant Cluster Of Differentiation (CD163)
Sign In for Pricing
View Details